100%(22)22 out of 22 people found this document helpful
This preview shows page 17 - 18 out of 18 pages.
groups known as cervicitis group one with 116 members and cervicitis group two (non-specific cervicitis) with 96 applicants. In cervicitis group one, azithromycin reduced cervicitis at follow-up in 23 out of 116 of the members with the prevalence of chlamydia and mycoplasma genitalium. No effect noted with the treatment of azithromycin in patient’s in the cervicitis group two. The treatment did not reduce symptoms associated with vaginal complaints. The study demonstrates that azithromycin 1 gm is effective at reducing cervicitis in populations with high prevalence of chlamydia and mycoplasma genitalium.How did the study support Ms. Campbell’s case: The research data supports the theory that azithromycin is effective for symptoms associated with cervicitis in the presence of chlamydia. Chlamydia and Neisseria gonorrhea exists as coinfections this research supports the statistic that a reduction in symptoms is identified when treated for cervicitis with chlamydial infection.
ReferencesBornstein, M., Ahmed, F., Barrow, R., Risley, J. F., Simmons, S., & Workowski, K. A. (2017). Factors associated with primary care physician knowledge of the recommended regimen for treating gonorrhea. Sexually Transmitted Diseases, 44(1), 14-17. Dickson, C., Arnason, T., Friedman, D. S., Metz, G., & Grimshaw, J. M. (2017). A systematic review and appraisal of the quality of practice guidelines for the management of Neisseria gonorrhoeae. Sex Transm Infect, 93(7), 487-492. Retrieved from Kidd, S., & Workowski, K. A. (2015). Management of gonorrhea in adolescents and adults in the United States. Clinical Infectious Diseases, 61 (8), 785-801. doi: 10.1093/cid/civ731.Lusk, M. J., Garden, F. L., Cumming, R. G., Rawlinson, W. D., Naing, Z. W., & Konecny, P. (2017). Cervicitis: A prospective observational study of empiric azithromycin treatment in women with cervicitis and nonspecific cervicitis. International Journal of STD & AIDS, 28(2), 120-126. Retrieved from 10.1177/0956462416628319Kirkcaldy, R. D., Hook III, E. W., Soge, O. O., Del Rio, C., Kubin, G., Zenilman, J. M., & Papp, J. R. (2015). Trends in Neisseria gonorrhea susceptibility to cephalosporins in the United States, 2006-2014. JAMA, 314(17), 1869-1871. Mayor, M. T., Roett, M. A., & Uduhiri, K. A. (2012). Diagnosis and management of gonococcal infections. American Academy Family Physician, 86(10), 931-938. Retrieved from Schuiling, K. D. (2017). Women’s Gynecologic Health. [South University]. Retrieved from